SML2607

Clevidipine Butyrate

≥98% (HPLC)

• 同義詞: 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3-methyl 5-[(1-oxobutoxy)methyl] ester, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl- 3,5-pyridinedicarboxylic acid methyl (1-oxobutoxy)methyl ester, H 324/38
• 經驗公式（希爾表示法）: C₂₁H₂₃Cl₂NO₆
• CAS號碼: 167221-71-8
• 分子量：: 456.32
• MDL號碼: MFCD00940070
• 分類程式碼代碼: 12352200
• NACRES: NA.77

屬性

• 化驗: ≥98% (HPLC)
• 形狀: powder
• 顏色: white to beige
• 溶解度: DMSO: 2 mg/mL, clear
• 儲存溫度: 2-8°C
• SMILES 字串: Clc1c(cccc1C2C(=C(NC(=C2C(=O)OC)C)C)C(=O)OCOC(=O)CCC)Cl
• InChI: 1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3
• InChI 密鑰: KPBZROQVTHLCDU-UHFFFAOYSA-N

描述

生化／生理作用

Clevidipine is a short acting, third generation dihydropyridine calcium channel blocker that is highly selective for vascular L-type calcium channels. Clevidipine has no effect on myocardial contractility or cardiac conduction.

short acting, calcium channel blocker that is highly selective for vascular L-type calcium channels

安全資訊

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H301,H361d
• 防範說明: P202 - P264 - P280 - P301 + P310 - P405 - P501
• 危險分類: Acute Tox. 3 Oral - Repr. 2
• 儲存類別代碼: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable